Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mou

Showing results (31-40 of 10,382) with videos related to

Pageof 1,039
Sort By:
Biotechnology Advances|January 1, 1983
Process dynamics, instrumentation and controlD G Mou
Journal of Clinical Hypertension (Greenwich, Conn.)|September 12, 2015
Does Anticomplement Therapy Have a Role in the Management of Malignant Hypertension?Han-Mou Tsai
Expert Review of Cardiovascular Therapy|December 19, 2006
ADAMTS13 and microvascular thrombosisHan-Mou Tsai
Lancet (London, England)|April 24, 2007
Taiwan-China health partnership is urgently needed for allSheng-Mou Hou
The American Journal of Medicine|April 1, 2019
Thrombotic Thrombocytopenic Purpura: Beyond Empiricism and Plasma ExchangeHan-Mou Tsai
Scientific Reports|August 21, 2025
Mirabegron nighttime versus daytime dosing for women with overactive bladder syndrome: a randomized controlled trialSheng-Mou Hsiao
Seminars in Thrombosis and Hemostasis|November 25, 2003
Shear stress and von Willebrand factor in health and diseaseHan-Mou Tsai
Bioinformatics (Oxford, England)|October 30, 2004
Relation between weight matrix and substitution matrix: motif search by similarityWei-Mou Zheng
International Journal of Hematology|January 9, 2010
Pathophysiology of thrombotic thrombocytopenic purpuraHan-Mou Tsai
Kidney International|February 2, 2010
Excessive activation of the complement system in atypical hemolytic uremic syndrome: is it ready for prime time?Han-Mou Tsai
Pageof 1,039

Showing results (31-40 of 10,382) with videos related to

Sort By:
Pageof 1,039
Biotechnology Advances|January 1, 1983
Process dynamics, instrumentation and controlD G Mou
Journal of Clinical Hypertension (Greenwich, Conn.)|September 12, 2015
Does Anticomplement Therapy Have a Role in the Management of Malignant Hypertension?Han-Mou Tsai
Expert Review of Cardiovascular Therapy|December 19, 2006
ADAMTS13 and microvascular thrombosisHan-Mou Tsai
Lancet (London, England)|April 24, 2007
Taiwan-China health partnership is urgently needed for allSheng-Mou Hou
The American Journal of Medicine|April 1, 2019
Thrombotic Thrombocytopenic Purpura: Beyond Empiricism and Plasma ExchangeHan-Mou Tsai
Scientific Reports|August 21, 2025
Mirabegron nighttime versus daytime dosing for women with overactive bladder syndrome: a randomized controlled trialSheng-Mou Hsiao
Seminars in Thrombosis and Hemostasis|November 25, 2003
Shear stress and von Willebrand factor in health and diseaseHan-Mou Tsai
Bioinformatics (Oxford, England)|October 30, 2004
Relation between weight matrix and substitution matrix: motif search by similarityWei-Mou Zheng
International Journal of Hematology|January 9, 2010
Pathophysiology of thrombotic thrombocytopenic purpuraHan-Mou Tsai
Kidney International|February 2, 2010
Excessive activation of the complement system in atypical hemolytic uremic syndrome: is it ready for prime time?Han-Mou Tsai
Pageof 1,039